Patents by Inventor Yoshiki Miyagawa

Yoshiki Miyagawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11969459
    Abstract: The present inventors have found that HMGB1 fragment peptides having a particular amino acid sequence exhibit the effects of improvement of cardiac function, inhibition of cardiomyocyte hypertrophy, inhibition of myocardial fibrosis, and promotion of angiogenesis in an animal model of dilated cardiomyopathy, that the particular HMGB1 fragment peptides also exhibit the effects of improvement of cardiac function, inhibition of cardiomegaly, inhibition of cardiomyocyte hypertrophy, inhibition of myocardial fibrosis, and promotion of angiogenesis in an animal model of ischemic cardiomyopathy caused by old myocardial infarction, and that the particular HMGB1 fragment peptides exhibit the effects of inhibition of cardiomyocyte hypertrophy and inhibition of myocardial fibrosis in an animal model of hypertensive cardiomyopathy.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: April 30, 2024
    Assignees: StemRIM Inc., OSAKA UNIVERSITY
    Inventors: Katsuto Tamai, Yoshiki Sawa, Shigeru Miyagawa, Takashi Kido, Takasumi Goto, Takehiko Yamazaki
  • Publication number: 20240122533
    Abstract: The present invention relates to an evaluation device 4 for evaluating the severity of pneumonia in a target patient, comprising: an acquisition unit 42 for acquiring a respiratory waveform of the target patient; a calculation unit 43 for calculating a value of an index indicating instability of a respiratory cycle or a respiratory frequency from the respiratory waveform; and an evaluation unit 44 for evaluating the severity based on the calculated value.
    Type: Application
    Filed: November 15, 2021
    Publication date: April 18, 2024
    Inventors: Shigeru MIYAGAWA, Yoshiki SAWA, Hidetsugu ASANOI, Sunao IKEGAWA
  • Publication number: 20240082154
    Abstract: The present invention provides clinically applicable, safe and convenient, pharmaceutical compositions and methods for disease site-specific treatment. The pharmaceutical composition for disease site-specific treatment methods comprises a stealth liposome having a prostaglandin I2 receptor agonist encapsulated therein.
    Type: Application
    Filed: October 23, 2023
    Publication date: March 14, 2024
    Inventors: Yoshiki Sawa, Shigeru Miyagawa, Yoshiki Sakai, Yasuhiro Yanagi
  • Patent number: 11223773
    Abstract: A WIFI camera with an animated liquid crystal display (LCD) screen includes a camera body, an induction display mechanism connected to the camera body, and a temperature and humidity detecting mechanism connected to the camera body. The induction display mechanism is configured to display a working state of the camera body. The temperature and humidity detecting mechanism is configured to monitor external temperature and humidity.
    Type: Grant
    Filed: August 2, 2021
    Date of Patent: January 11, 2022
    Assignee: NSK CO., LTD.
    Inventor: Yoshiki Miyagawa
  • Patent number: D955461
    Type: Grant
    Filed: June 4, 2021
    Date of Patent: June 21, 2022
    Assignee: NSK CO., LTD.
    Inventor: Yoshiki Miyagawa